• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

去氨加压素治疗儿童夜间遗尿症。

DDAVP in childhood nocturnal enuresis.

作者信息

Tuvemo T

出版信息

Acta Paediatr Scand. 1978 Nov;67(6):753-5. doi: 10.1111/j.1651-2227.1978.tb16255.x.

DOI:10.1111/j.1651-2227.1978.tb16255.x
PMID:568870
Abstract

A double-blind study of 18 children aged 6--12 years suffering from primary nocturnal enuresis without signs of underlying organic disease is reported. 20 microgram of DDAVP (desamino-D-arginine vasopressin, Minirin) was given intranasally at bedtime. The effect was prompt and satisfactory in 8 children and relatively good in another 8 children. No adverse effects were noted. DDAVP is advocated for temporary use in children with nocturnal enuresis needing immediate help.

摘要

报告了一项针对18名6至12岁原发性夜间遗尿症儿童的双盲研究，这些儿童无潜在器质性疾病迹象。睡前经鼻给予20微克去氨加压素（弥凝）。8名儿童效果迅速且令人满意，另外8名儿童效果相对较好。未观察到不良反应。对于急需帮助的夜间遗尿症儿童，提倡临时使用去氨加压素。

相似文献

1
DDAVP in childhood nocturnal enuresis.去氨加压素治疗儿童夜间遗尿症。
Acta Paediatr Scand. 1978 Nov;67(6):753-5. doi: 10.1111/j.1651-2227.1978.tb16255.x.
2
Desmopressin in nocturnal enuresis.去氨加压素治疗夜间遗尿症。
Arch Dis Child. 1982 Feb;57(2):137-40. doi: 10.1136/adc.57.2.137.
3
Desmopressin in the management of nocturnal enuresis in children: a double-blind study.去氨加压素治疗儿童夜间遗尿症：一项双盲研究。
Pediatrics. 1978 Dec;62(6):970-4.
4
Desamino-D-arginine vasopressin in childhood nocturnal enuresis.
J Urol. 1985 Jan;133(1):65-6. doi: 10.1016/s0022-5347(17)48785-4.
5
Management of nocturnal enuresis with a vasopressin analogue.
J Urol. 1984 May;131(5):925-7. doi: 10.1016/s0022-5347(17)50714-4.
6
DDAVP for adult enuresis--a preliminary report.
Br J Urol. 1982 Jun;54(3):256-8. doi: 10.1111/j.1464-410x.1982.tb06970.x.
7
[Application of 1-deamino-8-D-arginin vasopressin (DDAVP) in symptomatic treatment of nocturnal enuresis (author's transl)].
Bratisl Lek Listy. 1979 Dec;72(6):670-6.
8
[DDAVP in the treatment of nocturnal enuresis in children].
Minerva Pediatr. 1980 Nov 15;32(21):1255-7.
9
[The use of DDAVP (desmopressin) in primary nocturnal enuresis].
Minerva Pediatr. 1982 Feb 15;34(3):131-4.
10
DDAVP in young enuretic patients: a double-blind trial.
Br J Urol. 1984 Aug;56(4):376-8. doi: 10.1111/j.1464-410x.1984.tb05824.x.

引用本文的文献

1
Comparative tolerability of drug treatment for nocturnal enuresis in children.儿童夜间遗尿症药物治疗的耐受性比较
Drug Saf. 2004;27(10):717-27. doi: 10.2165/00002018-200427100-00002.
2
Desmopressin for nocturnal enuresis in children.去氨加压素用于治疗儿童夜间遗尿症。
Cochrane Database Syst Rev. 2000;2002(2):CD002112. doi: 10.1002/14651858.CD002112.
3
Hyponatremia in patients with nocturnal enuresis treated with DDAVP.使用去氨加压素治疗的夜间遗尿症患者的低钠血症。
Eur J Pediatr. 1996 Nov;155(11):959-62. doi: 10.1007/BF02282887.
4
Primary nocturnal enuresis and desmopressin treatment: do psychosocial factors affect outcome?
Eur Child Adolesc Psychiatry. 1996 Jun;5(2):101-9. doi: 10.1007/BF01989502.
5
Side effects and complications of treatment with desmopressin for enuresis.去氨加压素治疗遗尿症的副作用及并发症
J Natl Med Assoc. 1994 Oct;86(10):775-8.
6
Nocturnal enuresis.夜间遗尿症。
Pediatr Nephrol. 1995 Feb;9(1):94-103.
7
A comparison of amitriptyline, vasopressin and amitriptyline with vasopressin in nocturnal enuresis.
Pediatr Nephrol. 1995 Aug;9(4):438-40. doi: 10.1007/BF00866722.
8
Desmopressin in nocturnal enuresis.去氨加压素治疗夜间遗尿症。
Arch Dis Child. 1982 Feb;57(2):137-40. doi: 10.1136/adc.57.2.137.
9
Comparison of desmopressin and enuresis alarm for nocturnal enuresis.去氨加压素与遗尿报警器治疗夜间遗尿症的比较。
Arch Dis Child. 1986 Jan;61(1):30-3. doi: 10.1136/adc.61.1.30.
10
Comparison of intranasal and oral desmopressin for nocturnal enuresis.鼻内与口服去氨加压素治疗夜间遗尿症的比较。
Arch Dis Child. 1987 Jul;62(7):674-7. doi: 10.1136/adc.62.7.674.